Drugs for Lateral Sclerosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 339)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Mexiletine |
Approved, Investigational |
Phase 4 |
|
5370-01-4, 31828-71-4 |
4178 |
Synonyms:
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(±)-1-(2,6-dimethylphenoxy)propan-2-amine
(2Rs)-1-(2,6-Dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-Dimethylphenoxy)-2-propanamine
1-Methyl-2-(2,6-xylyloxy)ethanamine
Boehringer ingelheim brand OF mexiletine hydrochloride
KO-1173
KO-1173 CL
KO-1173-CL
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
|
Mexilétine
MEXILETINE HCL
Mexiletine hydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexitil
MEXITIL P.L.
Mexitil PL
Mexitil®
Mexityl
Novo mexiletine
Novo-mexiletine
Novopharm brand OF mexiletine hydrochloride
|
|
2 |
|
Dronabinol |
Approved, Illicit |
Phase 4 |
|
1972-08-3 |
16078 |
Synonyms:
&Delta
Δ<sup>9</sup>-THC|Abbott 40566|delta9-THC|Marinol®|tetrahydrocannabinol|THC
(-)- delta 9-Tetrahydrocannabinol
(-)-3,4-trans-delta1-Tetrahydrocannabinol
(-)-3,4-trans-Δ1-Tetrahydrocannabinol
(-)-delta 1-Tetrahydrocannabinol
(-)-delta 9-THC
(-)-delta 9-trans-Tetrahydrocannabinol
(-)-delta1-Tetrahydrocannabinol
(-)-delta9-Tetrahydrocannabinol
(-)-delta9-THC
(-)-delta9-trans-Tetrahydrocannabinol
(-)-trans-delta 1-Tetrahydrocannabinol
(-)-trans-delta 9-Tetrahydrocannabinol
(-)-trans-delta 9-THC
(-)-trans-delta1-Tetrahydrocannabinol
(-)-trans-delta9-Tetrahydrocannabinol
(-)-trans-delta9-THC
(-)-trans-Δ1-Tetrahydrocannabinol
(-)-trans-Δ9-Tetrahydrocannabinol
(-)-trans-Δ9-THC
(-)-Δ1-Tetrahydrocannabinol
(-)-Δ9-Tetrahydrocannabinol
(-)-Δ9-THC
(-)-Δ9-trans-tetrahydrocannabinol
(L)-delta 1-Tetrahydrocannabinol
(l)-delta1-Tetrahydrocannabinol
(l)-Δ1-Tetrahydrocannabinol
14C-delta 1-Tetrahydrocannabinol
1-trans-delta 9-Tetrahydrocannabinol
1-trans-delta-9-Tetrahydrocannabinol
1-trans-Δ-9-tetrahydrocannabinol
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
6H-DIBENZO(B,D)PYRAN-1-OL, 6A,7,8,10A-TETRAHYDRO-6,6,9-TRIMETHYL-3-PENTYL-, (6AR,10AR)-
9 Ene tetrahydrocannabinol
9-Ene-tetrahydrocannabinol
9-tetrahydrocannabinol
9-THC
ABBOTT 40566
ABBOTT-40566
Dea No. 7369
Dea No. 7370
delta 1-Tetrahydrocannabinol
delta 1-THC
delta 9-Tetrahydrocannabinol
delta 9-THC
delta 9-trans-Tetrahydrocannabinol
Delta(1)-Tetrahydrocannabinol
delta(1)-THC
delta(9)-Tetrahydrocannabinol
Delta(9)-THC
delta1-Tetrahydrocannabinol
|
delta1-THC
delta9-Tetrahydrocannabinol
DELTA-9-TETRAHYDROCANNABINOL
delta9-THC
DELTA-9-THC
delta9-trans-Tetrahydrocannabinol
Deltanyne
Dronabinol
Dronabinol [Usan:Inn]
DRONABINOLEN
Dronabinolum
Dronabinolum [Latin]
Exocyclic delta (9)(11)-tetrahydrocannabiol
J882F
L-delta 1-trans-Tetrahydrocannabinol
l-delta1-trans-Tetrahydrocannabinol
L-trans-delta 9-Tetrahydrocannabinol
l-trans-delta9-Tetrahydrocannabinol
l-trans-Δ9-Tetrahydrocannabinol
l-Δ1-trans-Tetrahydrocannabinol
Marinol
NSC-134454
Primolut
QCD 84924
QCD-84924
Solvay brand OF tetrahydrocannabinol
SP 104
SP-104
Syndros
Tetrahydrocannabinol
Tetrahydrocannabinol, (6ar-cis)-isomer
Tetrahydrocannabinol, (6as-cis)-isomer
Tetrahydrocannabinol, (6a-trans)-isomer
Tetrahydrocannabinol, trans isomer
Tetrahydrocannabinol, trans-(+-)-isomer
Tetrahydrocannabinol, trans-isomer
THC
trans-(-)-delta9-Tetrahydrocannabinol
trans-(-)-Δ9-Tetrahydrocannabinol
trans-delta (-)-9-Tetrahydrocannabinol
trans-delta 9-Tetrahydrocannabinol
trans-delta9-Tetrahydrocannabinol
trans-Δ9-Tetrahydrocannabinol
Δ(1)-tetrahydrocannabinol
Δ(9)-THC
Δ1-Tetrahydrocannabinol
Δ1-THC
Δ9-tetrahydrocannabinol
Δ-9-tetrahydrocannabinol
Δ9-THC
Δ-9-THC
Δ9-trans-Tetrahydrocannabinol
|
|
3 |
|
Cannabidiol |
Approved, Investigational |
Phase 4 |
|
13956-29-1 |
521372 644019 |
Synonyms:
(−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol
(−)-trans-cannabidiol
(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol
BTX-1503
CANNABIDIOL
CBD
CBD|Epidiolex®|GWP42003-P|nabiximols (CBD + THC, fixed-dose oral spray)|Sativex® (CBD + THC, fixed-dose oral spray)
|
EPIDIOLEX
GWP42003
GWP-42003
GWP42003-P
GWP-42003-P
Δ1(2)-trans-cannabidiol
|
|
4 |
|
Coconut |
Approved |
Phase 4 |
|
|
|
5 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
6 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
7 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
8 |
|
Olanzapine |
Approved, Investigational |
Phase 2, Phase 3 |
|
132539-06-1 |
135398745 4585 |
Synonyms:
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-B][1,5]BENZODIAZEPINE
ARKOLAMYL
Lanzac
LY170053
LY-170053
LY-170053|Zyprexa®
Olansek
OLANZAPIN
Olanzapina
|
OLANZAPINE
Olanzapine pamoate
Olanzapinum
Symbyax
ZALASTA
Zolafren
Zydis
Zyprexa
Zyprexa intramuscular
Zyprexa zydis
|
|
9 |
|
Valproic acid |
Approved, Investigational |
Phase 3 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 Propylpentanoic acid
2-N-PROPYL-4-PENTENOIC ACID
2-N-Propyl-N-valerate
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-Propylpentanoic acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-Propylvaleric acid
44089
4-Heptanecarboxylate
4-Heptanecarboxylic acid
A-44090
A-44090|Depakote®|Epilim®|valproate sodium
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acido valproico
ácido valproico
Acidum valproicum
Alti-valproic
Apo-divalproex
Apo-valproic
Apo-valproic syrup
Avugane
Baceca
Calcium valproate
Calcium, valproate
Convulex
Convulsofin
Delepsine
Depacon
Depakene
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Deproic
Di-N-propylacetate
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-n-propylessigsäure
Dipropyl acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DOM-divalproex
Dom-valproate
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
Epiject i.v.
Epilex
Epilim
|
Epival
Epival er
Ergenyl
Gen-divalproex
Kyselina 2-propylvalerova
LEP321
Magnesium valproate
Med valproic
Mylproin
Myproate
Myproic acid
N-Dipropylacetic acid
N-DPA
Novo-divalproex
Novo-valproic
Novo-valproic - ecc
Novo-valproic soft gel cap
NSC-93819
Nu-valproic
PEAC
Penta-valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
Ratio-valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
Sandoz valproic
Savicol
Semisodium valproate
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
Sprinkle
STAVZOR
Valcote
Valparin
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
VALPROIC ACID
Valproic acid usp
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
|
|
10 |
|
Ceftriaxone |
Approved |
Phase 3 |
|
73384-59-5 |
5479530 |
Synonyms:
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Anhydrous ceftriaxone sodium
Benaxona
Biotrakson
Boehringer mannheim brand OF ceftriaxone sodium
C18H18N8O7S3
Cefatriaxone
Cefaxona
Ceftrex
Ceftriaxon
Ceftriaxon curamed
Ceftriaxon hexal
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxona andreu
Ceftriaxona LDP torlan
CEFTRIAXONE
Ceftriaxone irex
Ceftriaxone sodium
Ceftriaxone sodium, anhydrous
Ceftriaxone, disodium salt
Ceftriaxone, disodium salt, hemiheptahydrate
Ceftriaxonum
|
Ceftriaxonum [INN-Latin]
Ceftriazone
Columbia brand OF ceftriaxone
CTRX
Curamed brand OF ceftriaxone sodium
FIDATO
Fustery brand OF ceftriaxone sodium
Galen brand OF ceftriaxone sodium
Hexal brand OF ceftriaxone sodium
Hoffman la roche brand OF ceftriaxone sodium
Hoffman-la roche brand OF ceftriaxone sodium
Inibsa brand OF ceftriaxone sodium
Irex brand OF ceftriaxone
Lendacin
Longacef
Longaceph
Pisa brand OF ceftriaxone sodium
Rocefalin
Rocefin
Rocephin
Rocephine
Roche brand OF ceftriaxone sodium
Sodium, ceftriaxone
Syntex brand OF ceftriaxone sodium
Tacex
Terbac
|
|
11 |
|
Quinidine |
Approved, Investigational |
Phase 3 |
|
56-54-2, 130-95-0, 804-63-7 |
1065 441074 3034034 8549 |
Synonyms:
(−)-quinine
(-)-Quinine
(+)-Quinidine
(8R,9S)-Quinidine
(8S,9R)-Quinine
(R)-(−)-quinine
(R)-(-)-Quinine
(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-METHOXY-QUINOLIN-4-YL)-((2S,5S)-5-VINYL-1-AZA-BICYCLO[2.2.2]OCT-2-YL)-METHANOL
(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-METHOXY-4-QUINOLYL)-[(2R,4S,5R)-5-VINYL-2-QUINUCLIDINYL]METHANOL
(S)-(6-METHOXY-4-QUINOLYL)-[(2R,4S,5R)-5-VINYLQUINUCLIDIN-2-YL]METHANOL
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
(S)-[(4S,5R,7R)-5-ETHENYL-1-AZABICYCLO[2.2.2]OCTAN-7-YL]-(6-METHOXYQUINOLIN-4-YL)METHANOL
6-Methoxy-a-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6'-Methoxycinchonidine
6'-Methoxycinchonine
6-Methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
a-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Adaquin
Aflukin
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Alphapharm brand OF quinine sulfate
Apo quinidine
Apo-quinidine
Apotex brand OF quinidine sulfate
Aventis brand OF quinine bisulfate
beta-Quinine
Biquin Durules
Biquinate
Bisulfate, quinine
b-Quinine
Cardioquin
Chinidin
Chinidinum
Chinin
Chinine
Chininum
CIN-quin
Coccinine
Coco-Quinine
Conchinin
Conchinine
Conquinine
Duraquin
Fawns and mcallan brand OF quinidine sulfate
Fawns and mcallan brand OF quinine bisulfate
Fawns and mcallan brand OF quinine sulfate
Foy brand OF quinine sulfate
GNF-PF-506
GNF-Pf-506|Qualaquin®|Quinate®|quinine bisulphate|quinine sulfate
Hoechst brand OF quinine sulfate
Hydrochloride, quinine
Innotech brand OF quinine hydrochloride
Kinidin
Lafran brand OF quinine hydrochloride
Legatrim
|
Myoquin
Nelson brand OF quinidine sulfate
Novoquinidin
NSC-192949
Odan brand OF quinine sulfate
Pitayin
Pitayine
Plough brand OF quinine sulfate
Prosana brand OF quinine bisulfate
QUALAQUIN
Quinact
QUINAGLUTE
Quinaglute Dura-Tabs
Quinaglute®|Quinidex®|quinidine hydrochloride
Quinalan
Quinamm
QUINATE
Quinatime
Quinbisan
Quinbisul
Quincardine
Quindan
Quindine
Quinicardine
Quinidex
Quinidex Extentabs
Quinidina
QUINIDINE
Quinidine Gluconate
QUINIDINE HYDROCHLORIDE
Quinidine sulfate
Quinimax
Quinina
QUININE
Quinine bisulfate
QUININE BISULPHATE
Quinine Dab
Quinine hydrochloride
Quinine lafran
Quinine sulfate
Quinine sulphate
Quinine, anhydrous
Quinineanhydrous
Quinine-odan
Quinoctal
Quinoline alkaloid
Quinora
Quin-Release
Quinson
Quinsul
Robins brand OF quinidine sulfate
Strema
Sulfate, quinidine
Sulfate, quinine
Sulphate, quinine
Surquina
WR297608
Α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Β-quinine
|
|
12 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 3 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
13 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 3 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
14 |
|
Dextromethorphan |
Approved |
Phase 3 |
|
125-71-3 |
5362449 5360696 |
Synonyms:
(-)-3-Methoxy-17-methylmorphinan
(-)-3-Methoxy-N-methylmorphinan
(+)-DEXTROMETHORPHAN
(9S,13S,14S)-3-METHOXY-17-METHYLMORPHINAN
Antussan
Balminil DM
Balminil DM Children
Bayer select flu relief
Bayer select head & chest cold
Bayer select night time cold
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
Calmylin #1
Canfodion
Cerose-DM
Chloraseptic DM
Contac day & night cold/flu day caplets
Contac jr. non-drowsy formula
Contac nighttime cold medicine
Contac severe cold formula maximum strength
Contac severe cold formula non-drowsy
Coricidin syrup
Cosylan
Cough-X
Creo-Terpin
Delsym
Delsym Cough Formula
delta-Methorphan
Demorphan
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [Dcit]
DEX
DEXTROMETHORFAN
Dextromethorfan [Czech]
DEXTROMETHORPHAN
Dextromethorphan bromhydrate
Dextromethorphan bromide
Dextromethorphan hydrobromide
Dextromethorphan hydrobromide monohydrate
Dextromethorphan hydrobromide oros tablets
Dextromethorphan hydrobromide, (+-)-isomer
Dextromethorphan hydrobromide, monohydrate
Dextromethorphan hydrochloride
Dextromethorphan, (+-)-isomer
DEXTROMÉTHORPHANE
DEXTROMETHORPHANUM
DEXTROMETORFANO
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dexyromethorphan
Diabe-Tuss DM Syrup
Dimacol
DIMETANE-DX
Dimetapp DM
DM
D-Methorphan
D-Methorphan hydrobromide
Dormetan
Dormethan
Drixoral cough
Drixoral cough & congestion
Drixoral cough & sore throat
DXM
|
Endotussin-NN
Endotussin-NN pediatric
Hihustan M.
Hold
Hold DM
Hydrobromide, dextromethorphan
Hydrochloride, dextromethorphan
Koffex DM
L-3-Methoxy-17-methylmorphinan
Levomethorphan
Levomethorphan [Ban:Dcf:Inn]
Levomethorphane
Levomethorphane [INN-French]
Levomethorphanum
Levomethorphanum [INN-Latin]
Levometorfano
Levometorfano [INN-Spanish]
L-Methorphan
Medicon
Methorate
Methorate Hydrobromide
Methorphan
Metrorat
Naldecon-DX
Novahistex DM
Novahistine DM
Ornex severe cold formula
Orthoxicol
PediaCare 1
PediaCare cough-cold formula
Pertussin CS Children's Strength
Pertussin DM Extra Strength
Prestwick_686
Racemethorphan
Robitussin CF
Robitussin cold & cough
Robitussin cough calmers
Robitussin DM
Robitussin maximum strength cough
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin pediatric cough
Robitussin pediatric cough & cold
Robitussin Pediatric Cough Suppressant
Robitussin pediatric night relief
Romilar
Rondec DM
Ru-tuss expectorant
St. joseph cough syrup
Sucrets 4 Hour Cough Suppressant
Sudafed cough syrup
Triaminic
Triaminic DM Long Lasting for Children
Trind-DM
Trocal
Tusilan
Tussade
Tussar DM
Tussi-organidin
Tussi-organidin DM NR
Tussi-organidin DM-S NR
Tylenol cold and flu multi-symptom
Tylenol cold and flu no drowsiness
Tylenol cold no drowsiness
Tylenol cough + decongestant liquid
Tylenol cough liquid
Tylenol flu no drowsiness gelcaps
Vicks 44 Cough Relief
Viro-med
Δ-methorphan
|
|
15 |
|
Mecobalamin |
Approved, Investigational |
Phase 2, Phase 3 |
|
13422-55-4 |
|
Synonyms:
ASIMIL B-12
B-MAX
CO-METHYLCOBALAMIN
MeCbl
Mecobalamin
Mecobalamina
|
Mecobalaminum
Methyl vitamin B12
Methyl(III)cobalamin
Methylcob(III)alamin
Methylcobalamin
|
|
16 |
|
Lenograstim |
Approved, Investigational |
Phase 2, Phase 3 |
|
135968-09-1 |
|
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
GRANOCYTE-13
GRANOCYTE-34
Granulocyte colony stimulating factor 3 (CHO cell derived)
|
Granulocyte colony-stimulating factor lenograstim
Lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
RG-CSF
|
|
17 |
|
Hydroxocobalamin |
Approved |
Phase 2, Phase 3 |
|
13422-51-0 |
15589840 44475014 |
Synonyms:
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
ALPHAREDISOL
Axlon
Ciplamin H
Cobalex
Cobalin H
COBALIN-H
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Codroxomin
CYANOKIT
Docclan
Docelan
Docevita
Droxomin
Ducobee hy
Duradoce
|
Duralta-12
HEPAVIT
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxo-cobalamin
HYDROXOCOBALAMIN ACETATE
HYDROXOCOBALAMIN ANHYDROUS
Hydroxocobalamine
HYDROXOCOBALAMINUM ANHYDROUS
HYDROXOCOBEMINE
Hydroxomin
Hydroxycobalamin
MEGAMILBEDOCE
NEO-CYTAMEN
OH-CBL
Vitamin b-12b
|
|
18 |
|
Acetylcholine |
Approved, Investigational |
Phase 2, Phase 3 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
19 |
|
Minocycline |
Approved, Investigational |
Phase 3 |
|
10118-90-8, 13614-98-7 |
54675783 5281021 |
Synonyms:
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
ACNAMINO
AKNEMIN
AKNEMIN 50
Alti-Minocycline
Apo-Minocycline
ARESTIN
BLEMIX 100
BLEMIX 50
CYCLOMIN
DENTOMYCIN
DYNACIN
Gen-Minocycline
KLINOMYCIN
MINO
Minociclina
Minociclina [INN-Spanish]
Minociclinum
MINOCIN
|
MINOCIN 50
MINOCIN MR
MINOCYCLIN
MINOCYCLINE
MINOCYCLINE HCL
MINOCYCLINE HYDROCHLORIDE
MINOCYCLINUM
Minocyclinum [INN-Latin]
Minocyn
MINOGAL
MINOLIRA
Minomycin
Novo-Minocycline
NSC-141993
SEBOMIN
SEBREN MR
SOLODYN
VECTRIN
XIMINO
|
|
20 |
|
Mecasermin |
Approved, Investigational |
Phase 3 |
|
68562-41-4 |
|
Synonyms:
CEP-151
Human somatomedin C
IGF1
IGF-1
INCRELEX
INSULIN-LIKE GROWTH FACTOR 1
INSULIN-LIKE GROWTH FACTOR I
|
MECASERMIN
MECASERMIN RECOMBINANT
MECASERMIN RINFABATE
Mecasermina
MECHANO GROWTH FACTOR
MYOTROPHIN
SOMATOMEDIN-C
|
|
21 |
|
Citalopram |
Approved |
Phase 3 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
22 |
|
Edaravone |
Approved, Investigational |
Phase 3 |
|
89-25-8 |
4021 70335 |
Synonyms:
1 Phenyl 3 methyl 5 pyrazolone
1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one
1-Phenyl-3-methyl-2-pyrazolin-5-one
1-Phenyl-3-methyl-5-oxo-2-pyrazoline
1-Phenyl-3-methyl-5-oxopyrazole
1-Phenyl-3-methyl-5-pyrazolinone
1-Phenyl-3-methyl-5-pyrazolone
2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one
3 Methyl 1 phenyl 2 pyrazolin 5 one
3-Methyl-1-phenyl-1H-pyrazol-5-one
3-Methyl-1-phenyl-2-pyrazolin-5-one
3-Methyl-1-phenyl-2-pyrazoline-5-one
3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one
3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one
3-Methyl-1-phenyl-5-pyrazolone
3-Methyl-1-phenylpyrazol-5(4H)-one
3-Methyl-1-phenylpyrazol-5-one
3-Methyl-1-phenylpyrazolin-5-one
5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one
5-Methyl-2-phenylpyrazol-3-one
|
ANTIPYRINE RELATED COMPOUND A
C.I. developer 1
Developer Z
Edarabone
EDARAVONE
MCI 186
MCI-186
Methylphenylpyrazolone
N-Demethylantipyrine
N-Demethylantipyrine, 14C-labeled
Norantipyrine
Norphenazone
NSC-12
NSC-26139
NSC-2629
Phenyl methyl pyrazolone
Phenylmethylpyrazolone
Radicava
Radicut
|
|
23 |
|
Memantine |
Approved, Investigational |
Phase 2, Phase 3 |
|
41100-52-1, 19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
1,3-DIMETHYLAMINOADAMANTANE
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
AKATINOL
Axura
Axura®|Ebixa®|Namenda®
D-145
DMAA
DRG-0267
Ebixa
Exiba
FP-01
Lundbeck brand OF memantine hydrochloride
|
MARIXINO
Memantin
Memantina
Memantina [INN-Spanish]
MEMANTINE
Memantine [INN]
MEMANTINE HCL
Memantine hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
Namenda
NAMENDA XR
NEMDATINE
NSC-102290
SUN-Y7017
VALIOS
|
|
24 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
25 |
|
Tannic acid |
Approved |
Phase 3 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
26 |
|
Trazodone |
Approved, Investigational |
Phase 2, Phase 3 |
|
19794-93-5 |
5533 |
Synonyms:
2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
AF-1161
AF-1161|Desyrel®|Molipaxin®|Oleptro®
Apo trazodone
Apotex brand OF trazodone hydrochloride
Apothecon brand OF trazodone hydrochloride
Apo-trazodone
Aventis brand OF trazodone hydrochloride
Aventis pharma brand OF trazodone hydrochloride
Boehringer ingelheim brand OF trazodone hydrochloride
Bristol myers squibb brand OF trazodone hydrochloride
Bristol-myers squibb brand OF trazodone hydrochloride
Deprax
Desyrel
Farma lepori brand OF trazodone hydrochloride
Gen trazodone
Genpharm brand OF trazodone hydrochloride
Gen-trazodone
Hexal brand OF trazodone hydrochloride
J10.767K
Molipaxin
Neuraxpharm brand OF trazodone hydrochloride
Novo trazodone
Novopharm brand OF trazodone hydrochloride
Novo-trazodone
Nu pharm brand OF trazodone hydrochloride
|
Nu trazodone
Nu-pharm brand OF trazodone hydrochloride
Nu-trazodone
OLEPTRO
Pharmascience brand OF trazodone hydrochloride
PMS Trazodone
PMS-Trazodone
Ratio trazodone
Ratiopharm brand OF trazodone hydrochloride
Ratio-trazodone
RatioTrazodone
Searle brand OF trazodone hydrochloride
Sidmark brand OF trazodone hydrochloride
Thombran
Tradozone
Trazodon hexal
Trazodon neuraxpharm
Trazodona
TRAZODONE
Trazodone hydrochloride
Trazodon-neuraxpharm
TrazodonNeuraxpharm
Trazodonum
Trazon
TRIALODINE
Trittico
|
|
27 |
|
Dolutegravir |
Approved |
Phase 3 |
|
1051375-16-6 |
57414794 54726191 |
Synonyms:
DOLUTEGRAVIR
GSK 1349572
GSK1349572
GSK-1349572
|
S/GSK1349572
S-349572
TIVICAY
|
|
28 |
|
Lamivudine |
Approved, Investigational |
Phase 3 |
|
134678-17-4 |
60825 |
Synonyms:
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-2'-Deoxy-3'-thiacytidine
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
3TC
3'-Thia-2',3'-dideoxycytidine
BCH 189
BCH 189, (-)-
BCH-189
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
b-L-2',3'-Dideoxy-3'-thiacytidine
b-L-3'-Thia-2',3'-dideoxycytidine
Epivir
|
EPIVIR-HBV
Epzicom
GR-109714X
Hepitec
HEPTOVIR
LAMIVUDIN
LAMIVUDINA
LAMIVUDINE
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-isomer
LAMIVUDINUM
ZEFFIX
Β-L-2',3'-dideoxy-3'-thiacytidine
Β-L-3'-thia-2',3'-dideoxycytidine
|
|
29 |
|
Abacavir |
Approved, Investigational |
Phase 3 |
|
136470-78-5, 188062-50-2 |
441300 |
Synonyms:
(1S,4R)-4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol
{(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
ABACAVIR
Abacavir succinate
Abacavir sulfate
ABC
|
ATC CODE J05AF06
ATCVET CODE QJ05AF06
C14H18N6O
EPZICOM
Ziagen
|
|
30 |
|
Iron |
Approved |
Phase 2, Phase 3 |
|
7439-89-6 |
29936 |
Synonyms:
Carbonyl iron
Eisen
Electrolytic iron
Fe
FE (III) ion
Fe(3+)
Fe(III)
fer
Ferric ion
Ferric iron
Ferrum
|
Ferrum metallicum
Hierro
Iron powder
Iron(3+)
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, reduced
Reduced iron
|
|
31 |
|
Deferiprone |
Approved |
Phase 2, Phase 3 |
|
30652-11-0 |
2972 |
Synonyms:
1,2 Dimethyl 3 hydroxy 4 pyridinone
1,2 Dimethyl 3 hydroxypyrid 4 one
1,2 Dimethyl 3 hydroxypyridin 4 one
1,2-Dimethyl-3-hydroxy-4-pyridinone
1,2-Dimethyl-3-hydroxypyrid-4-one
1,2-Dimethyl-3-hydroxypyridin-4-one
3 Hydroxy 1,2 dimethyl 4 pyridinone
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
3-Hydroxy-1,2-dimethyl-4-pyridinone
APO-066
APO-66
CP20
CP-20
DEFERIPRON
DEFERIPRONA
DEFERIPRONE
DÉFÉRIPRONE
|
DEFERIPRONI
DEFERIPRONUM
DEFERYPRON
DIMETHYLHYDROXYPYRIDONE
DMOHPO
DN-18001AF
DN-180-01-AF
Ferriprox
HDMPP
HDMPP CPD
HDPP
L1
L-1
L1 Oral chelate
PL1
PL-1
|
|
32 |
|
Coal tar |
Approved |
Phase 2, Phase 3 |
|
8007-45-2 |
|
Synonyms:
|
33 |
|
Lithium carbonate |
Approved |
Phase 2, Phase 3 |
|
554-13-2 |
|
Synonyms:
CAMCOLIT 250
CAMCOLIT 400
Carbonic acid, dilithium salt
CP-1546761
CP-15467-61
Dilithium carbonate
ESKALITH
ESKALITH CR
LISKONUM
|
LITHANE
Lithii carbonas
LITHIUM CARBONATE
LITHOBID
LITHONATE
LITHOTABS
NSC-16895
PHASAL
|
|
34 |
|
Dopamine |
Approved |
Phase 3 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
35 |
|
Pramipexole |
Approved, Investigational |
Phase 3 |
|
104632-26-0, 104632-25-9, 104632-28-2 |
4885 119570 59868 |
Synonyms:
(-)-Pramipexole
(S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
2 Amino 6 propylaminotetrahydrobenzothiazole
2,6-BENZOTHIAZOLEDIAMINE, 4,5,6,7-TETRAHYDRO-N(SUP 6)-PROPYL-, (S)-
2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
2-Amino-6-propylaminotetrahydrobenzothiazole
4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine
6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
Dexpramipexole
Furfuryl Acetate
Mirapex
MIRAPEX ER
MIRAPEX EXTENDED RELEASE
Mirapex®|Mirapexin®|Sifrol®|SND-919CL2Y|U-98528E
MIRAPEXIN
NELIPRAX
OPRYMEA
PIPEXUS
Pramipexol
Pramipexol [Spanish]
Pramipexol dihydrobromide, (+-)-isomer
|
Pramipexol dihydrochloride, (S)-isomer
Pramipexol, (+-)-isomer
Pramipexol, (R)-isomer
Pramipexole
Pramipexole 2HCl Monohydrate
Pramipexole dihydrochloride
Pramipexole dihydrochloride anhydrous
Pramipexole hydrochloride
Pramipexole hydrochloride monohydrate
Pramipexolum
Pramipexolum [Latin]
Sifrol
Sifrole
SND 919
SND 919CL2X
SND-919
SND919CL2X
SND-919CL2X
SND-919CL2Y
SUD-919CL2Y
U-98528E
|
|
36 |
|
Sodium citrate |
Approved, Investigational |
Phase 3 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
37 |
|
Ravulizumab |
Approved, Investigational |
Phase 3 |
|
1803171-55-2 |
|
Synonyms:
ALXN1210
ALXN-1210
RAVULIZUMAB
|
RAVULIZUMAB-CWVZ
ULTOMIRIS
|
|
38 |
|
Ubidecarenone |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
303-98-0 |
5281915 |
Synonyms:
(all-e)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
(all-e)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-cyclohexadiene-1,4-dione
2-((all-e)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2,3-Dimethoxy-5-methyl-6-decaprenylbenzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiene-1,4-dione
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone
4-Ethyl-5-fluoropyrimidine
Adelir
all-trans-Ubiquinone
API 31510
API-31510
Aqua Q 10l10
Aqua Q10
Bio-quinon
Bio-quinone Q10
Coenzyme Q10
Coenzyme Q-10
CO-Enzyme Q10
CoQ
CoQ 10
CoQ10
Ensorb
Kaneka Q10
|
Kudesan
Li-Q-sorb
Liquid-Q
Neuquinon
Neuquinone
NSC-140665
NSC-140865
PureSorb Q 40
Q
Q 10AA
Q 199
Q10
Q-Gel
Q-Gel 100
Q-Ter
Ubidecarenone
UBIDECARENONE FOR SYSTEM SUITABILITY
Ubiquinone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
UBIQUINONE-10
Unbiquinone
Unispheres Q 10
|
|
39 |
|
Cyanocobalamin |
Approved, Nutraceutical |
Phase 2, Phase 3 |
|
68-19-9 |
24892734 16212801 44176380 |
Synonyms:
Anacobin
Bedoz
BEHEPAN
Berocca PN
Berubigen
BETALIN 12
Betalin 12 crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
CALOMIST
Cernevit-12
Cianocobalamina
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-b12
Cyanobalamin concentrate
Cyanocob(III)alamin
CYANOCOBALAMIN
Cyanocobalamin (JP15/usp)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalaminum
Cyanocobalmin
Cyanoject
CYANOVIT-B12
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
|
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Neuroforte-R
Normocytin
Novidroxin
NSC-80365
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
RUBIVITE
Rubramin
RUBRAMIN PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
RUVITE
Shovite
Sytobex
Vibal
Vibalt
Vibisone
Virubra
Vitabee 12
VITAMIN B 12
Vitamin b12
Vitamin b12 complex
VITAMIN B12 NOS
Vitamin b12 preparation
vitamine b12
Vitaped
Vitarubin
Vita-rubra
Vitral
VI-TWEL
|
|
40 |
|
D-Tyrosine |
Approved, Experimental, Investigational, Nutraceutical |
Phase 3 |
|
133585-56-5, 60-18-4, 556-02-5 |
1153 6057 |
Synonyms:
(-)-a-Amino-p-hydroxyhydrocinnamate
(-)-a-Amino-p-hydroxyhydrocinnamic acid
(-)-alpha-Amino-p-hydroxyhydrocinnamate
(-)-alpha-Amino-p-hydroxyhydrocinnamic acid
(-)-Α-amino-p-hydroxyhydrocinnamate
(−)-α-amino-p-hydroxyhydrocinnamic acid
(-)-Α-amino-p-hydroxyhydrocinnamic acid
(2S)-2-Amino-3-(4-hydroxyphenyl)propanoate
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPIONIC ACID
(2S)-2-AZANYL-3-(4-HYDROXYPHENYL)PROPANOIC ACID
(R)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(R)-3-(p-Hydroxyphenyl)alanine
(S)-(-)-Tyrosine
(S)-2-Amino-3-(p-hydroxyphenyl)propionate
(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(S)-3-(p-Hydroxyphenyl)alanine
(S)-a-Amino-4-hydroxybenzenepropanoate
(S)-a-Amino-4-hydroxy-benzenepropanoate
(S)-a-Amino-4-hydroxybenzenepropanoic acid
(S)-a-Amino-4-hydroxy-benzenepropanoic acid
(S)-alpha-Amino-4-hydroxybenzenepropanoate
(S)-alpha-Amino-4-hydroxy-benzenepropanoate
(S)-alpha-amino-4-Hydroxybenzenepropanoic acid
(S)-alpha-Amino-4-hydroxy-benzenepropanoic acid
(S)-Tyrosine
(S)-Α-amino-4-hydroxybenzenepropanoate
(S)-α-amino-4-hydroxybenzenepropanoic acid
2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoate
2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoic acid
2-Amino-3-(4-hydroxyphenyl)propanoate
|
2-Amino-3-(4-hydroxyphenyl)propanoic acid
2-Amino-3-(p-hydroxyphenyl)propionate
2-Amino-3-(p-hydroxyphenyl)propionic acid
3-(4-Hydroxyphenyl)-L-alanine
3-(p-Hydroxyphenyl)alanine
4-hydroxy-L-phenylalanine
6-Hydroxysandoricin
Benzenepropanoate
Benzenepropanoic acid
D-Tyr
D-Tyrosin
FEMA NO. 3736
L Tyrosine
LEVODOPA IMPURITY, L-TYROSINE-
LEVODOPA RELATED COMPOUND L-TYROSINE
L-p-Tyrosine
L-Tyrosin
L-tyrosine
Methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]-2-hydroxyacetic acid
NSC-82624
Para tyrosine
Para-tyrosine
p-Tyrosine
Tirosina
Tyr
Tyrosin
Tyrosine
Tyrosine, L isomer
Tyrosine, L-isomer
Tyrosinum
Y
|
|
41 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
42 |
|
Cobalamin |
Experimental |
Phase 2, Phase 3 |
|
13408-78-1 |
6857388 |
Synonyms:
5,6-Dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
a-(5,6-Dimethylbenzimidazolyl)cobamide
alpha-(5,6-Dimethylbenzimidazolyl)cobamide
b 12, Vitamin
b12, Vitamin
Cbl
Cob(III)alamin
Cobalamin (III)
Cobalamin(1+)
Cobalamin(III)
Cobalamine
|
Cobalamins
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Cyanocobalamin
Eritron
Hydroxomin
Rubivite
Rubratope-57
Rubratope-60
Ruvite
Vitamin b 12
Vitamin b12
Α-(5,6-dimethylbenzimidazolyl)cobamide
|
|
43 |
|
Dexetimide |
Withdrawn |
Phase 3 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
44 |
|
Simendan |
Investigational |
Phase 3 |
|
131741-08-7 |
|
Synonyms:
((4-(1,4,5,6-tetrahydro-4-Methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile
Dextrosimendan
Levosimendan
|
|
|
45 |
|
Nabiximols |
Investigational |
Phase 2, Phase 3 |
|
56575-23-6 |
|
Synonyms:
CANNABINOIDS
GW 1000
GW 1000-02
GW-1000
|
Nabiximols
SAB 378
SAB-378
SATIVEX
|
|
46 |
|
Ibudilast |
Investigational |
Phase 2, Phase 3 |
|
50847-11-5 |
3671 |
Synonyms:
2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine
3-Isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
3-Isobutyryl-2-isopropyl-pyrazolo(1,5-a)pyridine
3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine
AV411
AV-411
AV-411|KC-404|Ketas®|MN-166
Eyevinal
I0157_sigma
|
IBUDILAST
Ibudilastum
KC-404
Ke tas
Ketas
Lopac-I-0157
MN-166
Tocris-1694
UNII-m0TTH61XC5
|
|
47 |
|
Trichostatin A |
Experimental |
Phase 3 |
|
58880-19-6 |
5562 444732 |
Synonyms:
A-300-I
ANTIBIOTIC A-300
GNF-PF-1011
N-Hydroxy7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienimidate
|
TRICHOSTATIN
TRICHOSTATIN(S)
TSA
|
|
48 |
|
Antipsychotic Agents |
|
Phase 2, Phase 3 |
|
|
|
49 |
|
Antiemetics |
|
Phase 2, Phase 3 |
|
|
|
50 |
|
Analgesics |
|
Phase 2, Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 716)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Role of Non-invasive Ventilation in Amyotrophic Lateral Sclerosis: Volume Versus Pressure Mode |
Unknown status |
NCT00560287 |
Phase 4 |
|
2 |
Care (Canadian ALS Riluzole Evaluation) Multicentre Phase IV Comparative Study of the Effects of Riluzole 50mg Bid on the Survival of ALS Subjects Compared to Historical Controls |
Completed |
NCT00542412 |
Phase 4 |
Riluzole |
3 |
Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS) |
Completed |
NCT00613899 |
Phase 4 |
|
4 |
Mexiletine for the Treatment of Muscle Cramps in ALS |
Completed |
NCT01811355 |
Phase 4 |
Mexiletine;Placebo |
5 |
EMERALD TRIAL Open-Label Extension Study (EMERALD OLE) |
Not yet recruiting |
NCT04997954 |
Phase 4 |
MediCabilis CBD oil |
6 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Cu(II)ATSM in Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease |
Unknown status |
NCT04082832 |
Phase 2, Phase 3 |
Cu(II)ATSM;Placebos |
7 |
A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis |
Unknown status |
NCT00069186 |
Phase 3 |
Creatine Monohydrate |
8 |
Japanese Early-stage Clinical Trial of Ultra-high Dose Methylcobalamin for Amyotrophic Lateral Sclerosis: a Pivotal Phase 3 Randomized Controlled Study |
Unknown status |
NCT03548311 |
Phase 3 |
methylcobalamin;saline solution |
9 |
Randomized, Placebo-controlled Parallel Group Study for the Evaluation of an Oral Dose of 10mg Olanzapine in Combination With Riluzole for the Treatment of Loss of Appetite in Patients With Amyotrophic Lateral Sclerosis (ALS) |
Unknown status |
NCT00876772 |
Phase 2, Phase 3 |
Olanzapine |
10 |
Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS) in a Representative Iranian Population |
Unknown status |
NCT03272802 |
Phase 2, Phase 3 |
Edaravone;Riluzole |
11 |
A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB067 Administered to Adult Subjects With Amyotrophic Lateral Sclerosis and Confirmed Superoxide Dismutase 1 Mutation |
Completed |
NCT02623699 |
Phase 3 |
BIIB067 |
12 |
Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase 2/3 Study to Compare the Efficacy and Safety of Masitinib |
Completed |
NCT02588677 |
Phase 2, Phase 3 |
Masitinib (4.5);Riluzole;Placebo;Masitinib (3.0) |
13 |
Phase II/III, Multicenter, Randomized, Parallel Group, Double-blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole |
Completed |
NCT00868166 |
Phase 3 |
Olesoxime;Placebo Comparator;Riluzole |
14 |
An Expanded Controlled Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis in Double-Blind, Parallel-Group, Placebo-Controlled Manner (Phase 3) |
Completed |
NCT00424463 |
Phase 3 |
MCI-186;Placebo of MCI-186 |
15 |
An Exploratory Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (Severity Classification III) in Double-Blind, Parallel-Group, Placebo-Controlled Manner |
Completed |
NCT00415519 |
Phase 3 |
MCI-186;Placebo of MCI-186 |
16 |
Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement |
Completed |
NCT00386464 |
Phase 2, Phase 3 |
|
17 |
Randomized Crossover Design Trial of Vitamin E vs Placebo for Treatment of Cramps in Amyotrophic Lateral Sclerosis. |
Completed |
NCT00372879 |
Phase 3 |
|
18 |
Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT01933321 |
Phase 2, Phase 3 |
|
19 |
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT00445172 |
Phase 2, Phase 3 |
E0302 (mecobalamin) |
20 |
A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS |
Completed |
NCT03280056 |
Phase 3 |
|
21 |
A Phase II/III Study in Patients With Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT00444613 |
Phase 2, Phase 3 |
E0302 (mecobalamin);Placebo |
22 |
Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT00706147 |
Phase 2, Phase 3 |
Arimoclomol;Placebo |
23 |
Repetitive Transcranial Magnetic Stimulation in Amyotrophic Lateral Sclerosis |
Completed |
NCT00833820 |
Phase 2, Phase 3 |
|
24 |
A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability and Efficacy of Tirasemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT02496767 |
Phase 3 |
Tirasemtiv;Placebo tablets |
25 |
A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS |
Completed |
NCT00136110 |
Phase 3 |
Sodium Valproate |
26 |
Minocycline to Treat Amyotrophic Lateral Sclerosis |
Completed |
NCT00047723 |
Phase 3 |
minocycline |
27 |
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT00035815 |
Phase 3 |
Insulin like growth factor, type 1;Placebo |
28 |
Phase 2-3 - Memantine for Disability in Amyotrophic Lateral Sclerosis |
Completed |
NCT00353665 |
Phase 2, Phase 3 |
Memantine (Ebixa);riluzole;Placebo |
29 |
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS) |
Completed |
NCT00349622 |
Phase 3 |
ceftriaxone |
30 |
A Confirmatory Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis in Double-blind, Parallel-group, Placebo-controlled Manner. |
Completed |
NCT00330681 |
Phase 3 |
MCI-186;Placebo of MCI-186 |
31 |
A Double-Blind Controlled, Multicenter Phase II/III Study to Assess the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect in Patients With Amyotrophic Lateral Sclerosis |
Completed |
NCT00021697 |
Phase 3 |
AVP-923 |
32 |
An Open-label, 8- Week, Flexible Dose Trial of Escitalopram (Lexapro®) in Comorbid Major Depression With Amyotrophic Lateral Sclerosis and Multiple Sclerosis |
Completed |
NCT00965497 |
Phase 3 |
escitalopram |
33 |
A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of Botulinum Toxin Type B (Myobloc) in Sialorrhea in Amyotrophic Lateral Sclerosis |
Completed |
NCT00125203 |
Phase 2, Phase 3 |
Botulinum toxin type B (Myobloc) |
34 |
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS: Open-Label Extension for Patients Completing Study 3119002 |
Completed |
NCT03948178 |
Phase 3 |
Levosimendan |
35 |
An Open-label Safety Extension Study of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole |
Completed |
NCT01285583 |
Phase 2, Phase 3 |
TRO19622 |
36 |
A Phase 3, Open-Label Extension Study of Tirasemtiv for Patients With Amyotrophic Lateral Sclerosis (ALS) Who Completed VITALITY-ALS (CY 4031) |
Completed |
NCT02936635 |
Phase 3 |
tirasemtiv |
37 |
A Fase II, Randomized, Double-Blind, Placebo-Controlled, Multicentre Study for the Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Patients |
Completed |
NCT01776970 |
Phase 2, Phase 3 |
Cannabis Sativa extract Oromucosal spray |
38 |
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis |
Completed |
NCT01281189 |
Phase 3 |
Dexpramipexole;Placebo |
39 |
Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls. Analysis With 123I-FP-CIT (Datscan) and 123I-ADAM Brain SPECT |
Completed |
NCT01160263 |
Phase 3 |
SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM |
40 |
Efficacy and Safety Study of MCI-186 for Treatment of the Patients With Amyotrophic Lateral Sclerosis (ALS) 2 |
Completed |
NCT01492686 |
Phase 3 |
MCI-186;Placebo;MCI-186 in open label phase |
41 |
The Effect of Granulocyte Colony Stimulating Factor (GCSF) in the Treatment of Amyotrophic Lateral Sclerosis (ALS) Patients Referred to Tehran Imam Khomeini and Shariati Hospital Centers in 2013 |
Completed |
NCT01825551 |
Phase 2, Phase 3 |
Granulocyte Colony Stimulating Factor;Placebo |
42 |
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS |
Completed |
NCT03505021 |
Phase 3 |
Levosimendan;Placebo for levosimendan |
43 |
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis |
Completed |
NCT03491462 |
Phase 3 |
Arimoclomol;Placebo oral capsule |
44 |
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) |
Completed |
NCT00573443 |
Phase 3 |
dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg;dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg;Placebo |
45 |
A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety Study of a New 10% Ready To-use Liquid Human Intravenous Immunoglobulin (I10E) Versus Kiovig® in Patients With Multifocal Motor Neuropathy |
Completed |
NCT01951924 |
Phase 3 |
Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL);Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL) |
46 |
A Phase 1-3 Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION363 in Amyotrophic Lateral Sclerosis Patients With Fused in Sarcoma Mutations (FUS-ALS) |
Recruiting |
NCT04768972 |
Phase 3 |
ION363;Placebo |
47 |
A Randomised, Double-blind, Single-centre Study on the Safety, Tolerability and Efficacy of Cannabis Based Medicine Extract (MediCabilis CBD Oil) in Slowing the Disease Progression in Amyotrophic Lateral Sclerosis or Motor Neurone Disease Patients |
Recruiting |
NCT03690791 |
Phase 3 |
MediCabilis CBD Oil;Placebo Oil |
48 |
HEALEY ALS Platform Trial |
Recruiting |
NCT04297683 |
Phase 2, Phase 3 |
Zilucoplan;Verdiperstat;CNM-Au8;Pridopidine;SLS-005 Trehalose |
49 |
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial |
Recruiting |
NCT04302870 |
Phase 2, Phase 3 |
Memantine Hydrochloride Oral Solution;Trazodone Hydrochloride oral solution;Placebo oral solution |
50 |
A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel(Neuronata-R® Inj.) in Patients With Amyotrophic Lateral Sclerosis |
Recruiting |
NCT04745299 |
Phase 3 |
Riluzole;Placebo Comparator |
|